Activation of RAGE induces elevated O2- generation by mononuclear phagocytes in diabetes

被引:65
作者
Ding, Yong
Kantarci, Alpdogan
Hasturk, Hatice
Trackman, Philip C.
Malabanan, Alan
Van Dyke, Thomas E.
机构
[1] Boston Univ, Goldman Sch Dent Med, Dept Periodontol & Oral Biol, Sch Med, Boston, MA 02118 USA
[2] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02215 USA
[3] Boston Univ, Sch Med, Dept Med, Boston, MA 02215 USA
关键词
monocytes/macrophages; hyperglycemia; advanced glycation end products; oxidative stress;
D O I
10.1189/jlb.0406262
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Oxidative stress has been found to play a role in the pathogenesis of diabetic complications. The aim of this study was to define the oxidative burst of diabetic monocytes to characterize the phenotype associated with poor diabetic control. Superoxide (O-2(-)) is the first molecule generated during the respiratory burst of phagocytes by NADPH oxidase, and its generation by monocytes from 26 controls and 34 diabetic subjects was evaluated in this study. Under resting states or stimulation by PMA or opsonized zymosan, diabetic monocytes produce significantly more O-2(-) than nondiabetic cells. The increased O-2(-) generation was found to be correlated with glycemic control (glycated hemoglobin) of patients. To clarify the effects of hyperglycemia on O-2(-) generation, normal human monocytes were treated with receptor for advanced glycation endproducts (RAGE) ligands (AGE protein and S100B) or high glucose media before stimulation. RAGE ligands and high glucose concentration increased O-2(-) generation from human mononuclear phagocytes. RAGE ligands, specifically and potently, increased O-2(-) generation from mononuclear phagocytes, and high-glucose effects were associated with correspondingly increased osmotic pressure. Differentiated THP-1 cells, from a human monocytic cell line, were used as a model of human monocytes to study the effects of S100B, the RAGE ligand. It was confirmed that RAGE is involved in the priming of O-2(-) generation by S100B. This study demonstrates that RAGE ligands can contribute significantly to the hyper-responsive phenotype of diabetic monocytes, which might be reversible by blocking the RAGE or controlling the presence of RAGE ligands by controlling hyperglycemia.
引用
收藏
页码:520 / 527
页数:8
相关论文
共 39 条
[1]   THE RESPIRATORY BURST OF PHAGOCYTES [J].
BABIOR, BM .
JOURNAL OF CLINICAL INVESTIGATION, 1984, 73 (03) :599-601
[2]  
BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315
[3]   RESPIRATORY BURST ACTIVITY OF MONOCYTES FROM PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS [J].
CHANG, FY ;
SHAIO, MF .
DIABETES RESEARCH AND CLINICAL PRACTICE, 1995, 29 (02) :121-127
[4]  
CHANOCK SJ, 1994, J BIOL CHEM, V269, P24519
[5]   The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques - Role of glycemic control [J].
Cipollone, F ;
Iezzi, A ;
Fazia, M ;
Zucchelli, M ;
Pini, B ;
Cuccurullo, C ;
De Cesare, D ;
De Blasis, G ;
Muraro, R ;
Bei, R ;
Chiarelli, F ;
Schmidt, AM ;
Cuccurullo, F ;
Mezzetti, A .
CIRCULATION, 2003, 108 (09) :1070-1077
[6]   Diabetes guideline: A summary and comparison of the recommendations of the American Diabetes Association, Veterans Health Administration, and American Association of Clinical Endocrinologists [J].
Clark, MJ ;
Sterrett, JJ ;
Carson, DS .
CLINICAL THERAPEUTICS, 2000, 22 (08) :899-910
[7]  
Delamaire M, 1997, DIABETIC MED, V14, P29, DOI 10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO
[8]  
2-V
[9]   Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, are able to reduce superoxide anion production by NADPH oxidase in THP-1-derived monocytes [J].
Delbosc, S ;
Morena, M ;
Djouad, F ;
Ledoucen, C ;
Descomps, B ;
Cristol, JP .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2002, 40 (04) :611-617
[10]   Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications -: The effect of α-tocopherol supplementation [J].
Devaraj, S ;
Jialal, I .
CIRCULATION, 2000, 102 (02) :191-196